AOD-9604 in Prissé — Fat Loss Peptide Research Guide
AOD-9604 research guide for Prissé. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
For anyone in Prissé looking to source AOD-9604, the key fact to understand is that this compound is available only through an online research supply market. What this means for Prissé researchers is that your location matters far less than your ability to assess COA data — and those verification methods are available to every researcher. The core quality markers for AOD-9604 are HPLC purity ≥98%, molecular identity established via mass spectrometry, and a bacterial endotoxin panel — all documented in a lot-traced Certificate of Analysis. The sections below cover what Prissé researchers need to know about purchasing, testing, and working with AOD-9604 for scientific research use.
Understanding AOD-9604 — Biology & Evidence
AOD-9604 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Prissé studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
How to Source AOD-9604 — Vendor Guide
The most consistent path to quality AOD-9604 is starting with community forums — peptide forums track vendor quality over time that are more trustworthy than marketing materials. When reviewing a AOD-9604 COA, verify: the batch number traces to your order, HPLC purity is ≥98%, mass spec confirms the correct peptide, and endotoxin levels are at acceptable levels for the intended application. Community reputation in research forums is a useful additional signal to COA verification — vendors with multi-year positive track records have earned that standing through repeat quality delivery. Price is an ineffective primary criterion for AOD-9604 quality — research-grade synthesis and testing has genuine production costs that cannot be cut without consequences, so unusually low prices consistently indicate quality reductions.
Order AOD-9604 — ships to Prissé
COA-verified · International tracking · Research grade
Research compound status for AOD-9604 means risk characterisation relies on animal studies, in-vitro work, and limited human observations — rather than the controlled trials that generate pharmaceutical safety profiles. Proper handling of AOD-9604 requires sterile reconstitution technique — swabbed septum with alcohol prep pad, new needle for each draw, clean preparation area — and consistent cold chain handling. Verify the endotoxin level in your AOD-9604 batch COA before any protocol involving administration — look for results expressed as EU/mg or EU/mL and verify they are within the acceptable range for your research context. Protocol documentation — documenting product details, dates, and administration precisely — is a research best practice for AOD-9604 that makes anomalous results interpretable.
Frequently Asked Questions
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
